When I first began reading about these two drugs, they were ABT-199 and Obinutuzumab. Obinutuzumab really threw me at first. I thought I'd never learn to say it or spell it. In the last three weeks, they've both quickly begun to roll right off my tongue and fingertips. But from here on, I will refer to them by their current names: Venetoclax and Gazyva.